The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

Stopped early · Not applicable

Conditions studied: Schizophrenia

In brief

The objective of this study is to determine whether subjects with negative symptoms of schizophrenia have abnormal functioning of brain circuits relevant to reward processing, and to determine whether any such abnormalities are normalized by treatment with aripiprazole.

Key facts

Study ID

NCT00209027

Run by

Emory University

People needed

20

Starts

2005-04-01

Expected to finish

2011-04-01

Last updated by the study team

2013-12-06

Who can join

Age: 20 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Diagnosed with schizophrenia
• Male
• Age 20-50
• Right handed

You may not qualify if…

• No current or past drug or alcohol problems (dependance or abuse)
• Not color blind
• Control Subjects:
• Inclusion Criteria:
• Male
• Age 20-50
• Right handed
• Exclusion Criteria:
• No current psychiatric problems
• No current or past drug or alcohol problems
• Not color blind

Where it is running

• Atlanta VA Medical Center — Decatur, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.